Humboldt Fund

Founded -


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
The average size of a deal this fund participated in
Portfolio companies 9
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Machine Learning
  • Therapeutics
  • Artificial Intelligence
  • Food and Beverage

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Debut Biotech

$22M12 Aug 2021 San Diego, California, United States

Food and Beverage
Food Processing
Innovation Management
$47M23 Mar 2021 Delft, South Holland, Netherlands

Product Design
$16M01 Feb 2021 Cambridge, Massachusetts, United States


Food and Beverage
01 Dec 2020 China, Shanghai


Artificial Intelligence
Machine Learning
$75M12 Nov 2020 California, United States


Building Material
Other Textiles
Product Research
Renewable Energy
Synthetic Textiles
$45M13 Oct 2020 California, United States

Finch Therapeutics

Clinical Trials
Machine Learning
$90M17 Sep 2020 Massachusetts, United States


Advanced Materials
Health Care
$91M27 Jul 2020 California, United States


Artificial Intelligence
Machine Learning
$26M16 Aug 2019 California, United States
Compound Foods brews up $4.5M to make coffee without beans

– Compound Foods is a synthetic biology company that creates coffee without coffee beans.
– The company raised $4.5m in seed funding.
– Backers include Chris Sacca’s climate fund Lowercarbon Capital, SVLC, Humboldt Fund, Collaborative Fund, Maple VC, Petri Bio and angel investors like Nick Green, CEO of Thrive Market.

Debut Biotech Raises $22.6M in Series A Funding

– Debut Biotech is a San Diego, CA-based developer of a biomanufacturing platform harnessing cell-free enzymes.
– The company raised $22.6m in Series A funding.
– The round was led by Material Impact with participation from Cultivian Sandbox Ventures, Fine Structure Ventures, ACVC Ventures, Humboldt Fund, Cantos Ventures, as well as existing investors including KdT Ventures.
– The new capital will be used to commercialize ingredients developed from its proprietary cell-free biomanufacturing platform.


  • No reviews are submitted yet.
Related media
Top 20 investors in North America with the biggest sum of Early funding rounds in Nanotechnology industry over the recent years
If you have found a spelling error or the data isn’t actual, please, notify us by selecting that text and pressing Ctrl+Enter. Read more
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Humboldt Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: